Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

USP9X activates SARS-CoV-2. 1 / 1

| 1

➶

reach

"Please note that the study was performed on existing samples collected during standard diagnostic tests, posing no extra burden to patients.The dPCR assay was performed via the digital PCR chips (Thermofisher, cat#A26317) following the manufacturer's protocols, and QuantStudio 3D Digital The result was considered positive when the FAM signals of the SARS-CoV-2 target ≥ 3 with the VIC signals of the RNase P reference target ≥ 0, and negative when the FAM signals ≤ 2 with the VIC signals ≥ 60."

34051244

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...